| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/03/2011 | CA2769633A1 Crystallization method and bioavailability |
| 02/03/2011 | CA2769624A1 Fatty acids as anti-inflammatory agents |
| 02/03/2011 | CA2769525A1 Therapeutic agents for reducing parathyroid hormone levels |
| 02/03/2011 | CA2769340A1 Prodrugs comprising an insulin linker conjugate |
| 02/03/2011 | CA2769203A1 Liver x receptor agonists |
| 02/03/2011 | CA2768396A1 Dihydropyrimidone amides as p2x7 modulators |
| 02/03/2011 | CA2768232A1 Substituted benzamide derivatives as glucokinase (gk) activators |
| 02/03/2011 | CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | CA2766886A1 Piperidine derivatives and their use to treat obesity, diabetes, dyslipidemia and atherosclerosis |
| 02/02/2011 | EP2280021A1 Pharmaceutical formulations comprising insulin complexed with a diketopiperazine |
| 02/02/2011 | EP2280020A1 Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2280004A1 Pharmaceutique formulations comprising insulin complexed with a diketopiperazine |
| 02/02/2011 | EP2279758A2 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279742A2 Combinations for the treatment of immunoinflammatory disorders |
| 02/02/2011 | EP2279738A1 The use of quaternary pyridinium salts as vasoprotective agents |
| 02/02/2011 | EP2279734A1 Composition for preventing cardiovascular event in high-risk patient |
| 02/02/2011 | EP2279673A1 Compositions for lowering serum cholesterol |
| 02/02/2011 | EP2279173A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments |
| 02/02/2011 | EP2278976A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors |
| 02/02/2011 | EP2278966A2 Treatment with opioid antagonists and mtor inhibitors |
| 02/02/2011 | EP1288205B1 Novel phenylalanine derivatives |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | CN201727759U Pravastatin sodium enteric-coated capsule |
| 02/02/2011 | CN201727758U Pravastatin sodium enteric-coated tablet |
| 02/02/2011 | CN1980655B Lipase inhibitor |
| 02/02/2011 | CN1966484B New phenoxy eicosanoic acid derivative and its medical use |
| 02/02/2011 | CN101965337A Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 02/02/2011 | CN101965196A Sugar chain-related gene and use thereof |
| 02/02/2011 | CN101965184A Synthetic triterpenoids and methods of use in the treatment of disease |
| 02/02/2011 | CN101962365A Aminoindazole derivatives as protein-kinase inhibitors |
| 02/02/2011 | CN101962349A 3-Boc amidocyanogen-3-(3-nitryl-4-fluorophenyl) monoprop and preparation method thereof |
| 02/02/2011 | CN101961492A Ezetimibe compound preparation for treating dyslipidemia |
| 02/02/2011 | CN101961491A Novel blood pressure and blood fat reduction composition |
| 02/02/2011 | CN101961490A Compound composition containing nitrobrate |
| 02/02/2011 | CN101961485A Selenium-enriched collagen and inulin composition with functions of enhancing immunity and reducing blood sugar |
| 02/02/2011 | CN101961471A Traditional Chinese medicine for treating diabetic foot |
| 02/02/2011 | CN101961470A Traditional Chinese medicine for treating diabetic acral necrosis |
| 02/02/2011 | CN101961461A Novel Chinese medicinal material with various effects |
| 02/02/2011 | CN101961460A Chinese medicinal health-care composition and preparation method thereof |
| 02/02/2011 | CN101961448A Chinese medicament for treating diabetic gout |
| 02/02/2011 | CN101961440A Chinese medicament for treating diabetic stomach paralysis |
| 02/02/2011 | CN101961426A Puerh tea extract and extraction method |
| 02/02/2011 | CN101961425A Pu'er tea extract and preparation method and application thereof |
| 02/02/2011 | CN101961424A Pu-erh tea extract and preparation thereof |
| 02/02/2011 | CN101961423A Pu'er tea extractive and preparation method thereof |
| 02/02/2011 | CN101961422A Extractive of Pu'er tea and preparation method thereof |
| 02/02/2011 | CN101961421A Traditional Chinese medicine for treating diabetic nephropathy |
| 02/02/2011 | CN101961420A Traditional Chinese medicine for treating diabetic nephropathy |
| 02/02/2011 | CN101961410A Chinese medicament for treating diabetic heart disease |
| 02/02/2011 | CN101961401A Compound Chinese medicinal composition having effects of reducing weight, reducing fat, tonifying spleen and beautifying |
| 02/02/2011 | CN101961387A Traditional Chinese medicine for treating diabetic skin pruritus |
| 02/02/2011 | CN101961386A Traditional Chinese medicine for treating diabetic skin pruritus |
| 02/02/2011 | CN101961382A Medicinal composition for treating cardiovascular and cerebrovascular diseases and detection method thereof |
| 02/02/2011 | CN101961375A Extractive of Pu'er tea and preparation method thereof |
| 02/02/2011 | CN101961371A Method for extracting and separating ginsenoside, flavone and polysaccharide from sweet gynostemma pentaphylla |
| 02/02/2011 | CN101961363A Preparation method of active pseudo-ginseng slices |
| 02/02/2011 | CN101961362A Method for preparing active pseudo-ginseng granule |
| 02/02/2011 | CN101961361A Method for preparing active pseudo-ginseng |
| 02/02/2011 | CN101961352A Self-emulsified fish oil soft capsules without fishy smell |
| 02/02/2011 | CN101961346A Self-emulsified prebiotic-containing calcium-iron-zinc soft capsules and preparation method thereof |
| 02/02/2011 | CN101961342A Water soluble vitamin composition for injection and preparation method thereof |
| 02/02/2011 | CN101961341A Application of glucose lowering function of mogrosides |
| 02/02/2011 | CN101961336A Medicainal composition for treating type 2 diabetes of mammals including human beings |
| 02/02/2011 | CN101961333A A thiazolidinedione derivative and its use as antidiabetic |
| 02/02/2011 | CN101961324A Prescription and preparation method of etofbrate release capsules |
| 02/02/2011 | CN101961323A Self-emulsified resveratrol soft capsules |
| 02/02/2011 | CN101961322A Medicinal composition for treating hyperlipidaemia |
| 02/02/2011 | CN101961319A Silybin meglumine enteric agent with high bioavailability and preparation method thereof |
| 02/02/2011 | CN101961315A Ornithine aspartate liposome injection |
| 02/02/2011 | CN101961312A Lipoid acid composition for injection |
| 02/02/2011 | CN101961061A Pu-erh tea extract, preparation method and application |
| 02/02/2011 | CN101961060A Pu'er tea extract and preparation method and application |
| 02/02/2011 | CN101961059A Puer tea extract, preparation method and application |
| 02/02/2011 | CN101485679B Medicament for preventing and treating hyperlipemia |
| 02/02/2011 | CN101468029B Difructose anhydride-containing composition and use thereof |
| 02/02/2011 | CN101444542B Extracts from chlorella sorokiniana |
| 02/02/2011 | CN101407558B Preparation of Dendrobium nobile polysaccharide extract and use there |
| 02/02/2011 | CN101289418B Miglitol crystal and method for preparing same |
| 02/02/2011 | CN101119726B Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879869 Drugs for ameliorating postcibal hyperglycemia |
| 02/01/2011 | US7879864 Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes |
| 02/01/2011 | US7879848 Dipeptidyl Peptidase-IV inhibiting compounds, method of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 02/01/2011 | US7879362 Oral pharmaceutical compositions with controlled release and prolonged absorption |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | CA2688915C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/01/2011 | CA2494091C Substituted furo [2,3-b| pyridine derivatives |
| 02/01/2011 | CA2483002C New pharmaceutical composition |
| 02/01/2011 | CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 02/01/2011 | CA2466140C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 02/01/2011 | CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2453747C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use |
| 02/01/2011 | CA2453442C Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |